Follitropin and renal disorder Patient Reports February 12, 2012
Follitropin Side Effects Report #5090679-6
Follitropin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 16, 2006. Female patient, 37 years of age, was diagnosed with in vitro fertilisation and was treated with Follitropin. After drug was administered, patient experienced the following side effects: haemorrhage, ill-defined disorder, renal disorder. Follitropin dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN. Patient died.
Follitropin Side Effects Report #5116976-3
Follitropin side effect was reported by a Health Professional from UNITED KINGDOM on Sept 19, 2006. Female patient, 37 years of age, was diagnosed with in vitro fertilisation and was treated with Follitropin. After drug was administered, patient experienced the following side effects: haemorrhage, renal disorder. Follitropin dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN. Patient died.
Follitropin Side Effects Report #5834910-5
Follitropin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 25, 2008. Female patient, 37 years of age, was diagnosed with in vitro fertilisation and was treated with Follitropin. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, haemorrhage, pulmonary embolism
, renal disorder. Follitropin dosage: unknown. During the same period patient was treated with CHORIONIC GONADTROPIN. Patient was hospitalized. Patient died.Follitropin Side Effects Report #5526106-1
Follitropin side effect was reported by a Consumer or non-health professional from ITALY on Nov 11, 2007. Female patient, 36 years of age, was diagnosed with anovulatory cycle and was treated with Follitropin. After drug was administered, patient experienced the following side effects: disease progression, gallbladder disorder, malignant neoplasm of ampulla of vater, metastases to liver, metastases to lymph nodes, pancreatic neuroendocrine tumour, renal disorder. Follitropin dosage: unknown. During the same period patient was treated with CHORIONIC GONADOTROPIN, PROGESTERONE. Patient was hospitalized. Patient died.
Follitropin and renal disorder 